Specific Activity of α1Proteinase Inhibitor and α2Macroglobulin in Human Serum: Application to Insulin-Dependent Diabetes Mellitus
Clinical Immunology and Immunopathology · 1998-12 · 89 (3) · 247-259
DOI: 10.1006/clin.1998.4605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology and Immunopathology, 1998-12. Verfasst von C L Bristow und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dental Research Center, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, 27599, USA. bristowc@soda.dent.unc.edu. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: NIDCR NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dental Research Center, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, 27599, USA. bristowc@soda.dent.unc.edu
Förderung
- NIDCR NIH HHS
Zitieren
APA
Bristow, C. L., Di Meo, F., & Arnold, R. R. (1998). Specific Activity of α1Proteinase Inhibitor and α2Macroglobulin in Human Serum: Application to Insulin-Dependent Diabetes Mellitus. Clinical Immunology and Immunopathology, 89(3), 247-259. https://doi.org/10.1006/clin.1998.4605
Vancouver
Bristow CL, Di Meo F, Arnold RR. Specific Activity of α1Proteinase Inhibitor and α2Macroglobulin in Human Serum: Application to Insulin-Dependent Diabetes Mellitus. Clinical Immunology and Immunopathology. 1998;89(3):247-259. doi:10.1006/clin.1998.4605
BibTeX
@article{Bristow1998,
author = {Bristow, C L and Di Meo, F and Arnold, R R},
title = {Specific Activity of α1Proteinase Inhibitor and α2Macroglobulin in Human Serum: Application to Insulin-Dependent Diabetes Mellitus},
journal = {Clinical Immunology and Immunopathology},
year = {1998},
volume = {89},
number = {3},
pages = {247--259},
doi = {10.1006/clin.1998.4605}
}
EUVIMED